Electrophysiology involves the study of the electrical activity of the heart in order to diagnose and monitor any arrhythmia. Depending on the results of electrophysiological studies, treatment modalities such as medication, implantable medical devices, cardiac ablation, and surgery may be decided. Electronic signals have a specific travel pattern in the heart, which changes and becomes irregular due to diseases and conditions such as heart attack, old age and blood pressure.
In such cases, electrophysiology techniques are used to diagnose, monitor, and select the appropriate course of treatment mentioned above. Indications for electrophysiology include bradycardia, tachycardia, atrial fibrillation, ventricular tachycardia, ventricular fibrillation, and other arrhythmias. Generally, catheters are used for electrophysiology studies and cardiac ablation procedures.
Catheters can be used for imaging intracardiac electrograms, electrogram measurements, cardiac pacing, navigational mapping and more. The market for electrophysiology devices is highly competitive by nature, as well-known manufacturers such as Boston Scientific Corporation and Abbott Laboratories have technologically advanced and extensive product portfolios.
The market for electrophysiology devices is driven primarily by technological innovation. Manufacturers have adopted strategies such as integration and acquisition, in-depth research and development, and continuous product launches to effectively compete in the market. Commercially available electrophysiology products include Rhythmia HDx, Confirm Rx, Advisor FL, EnSite Precision, WorkMate Claris Recording System, and SJM Confirm Implantable Cardiac Monitor.
Electrophysiology Devices Market Drivers
The growing global spread of cardiovascular and related diseases is expected to have a positive impact on market growth. According to the World Health Organization (WHO), approximately 17 million people die of heart disease each year. In 2017, 2.7 to 6.1 million people in the United States suffered atrial fibrillation, the most common type of heart arrhythmia, according to the Centers for Disease Control and Prevention (CDC). The increasing incidence and prevalence of heart disease during the forecast period is expected to boost the market growth of electrophysiology devices. Early diagnosis has become very important in deciding the best treatment plan and improving medical outcomes, and faster diagnosis can significantly improve medical outcomes.
Leading manufacturers in the market are involved in the technological development of electrophysiology devices, which is expected to boost the market for electrophysiology devices. For example, manufacturers have invented wearable and implantable devices with smartphone connectivity, such as wearable holter monitors and implantable cardiac monitors. In 2017, St. Jude Medical received the CE mark for Certification Rx, the world’s first smartphone compatible implantable cardiac monitor, and Boston Scientific launched the Rhythmia HDx. In 2017, Abbott launched the new Ensite Precision Cardiac Mapping System. Siemens Healthcare launched a cardiovascular imaging and information solution called ‘Sango Dynamics’ at the American College of Cardiology in March 2018.
BioScience Webster launched the CARTO 3 System CARTO VISITAG module in March 2017 to simplify and standardize electrophysiology procedures. The market for global electrophysiology devices is expected to grow during the forecast period.
However, the high cost of these devices, one-time installation, strict regulations, alternative treatments, and high product returns can hinder market growth.Sample copy of research report request: https://www.coherentmarketinsights.com/insight/request-sample/1641Electrophysiology Devices Market Insights.Depending on the region, North America and Europe are expected to see significant growth in the electrophysiology devices market during the forecast period. There are well-known manufacturers in North America engaged in the research and development of these devices. Manufacturers such as Boston Scientific Corporation (US) and St. Jude Medical offer innovative products in the electrophysiology market.
Significant growth is expected in the North American market due to the acquisition of inorganic growth strategies such as manufacturers. In 2017, for example, Boston Scientific Corporation announced the acquisition of Apama Medical to bolster its electrophysiology portfolio. Significant growth is expected in the Asia-Pacific region due to the high prevalence of heart disease and the increasing availability of modern electrophysiology equipment in the region.
Key players in the electrophysiology devices market include Siemens AG, Boston Scientific Corporation, Abbott Laboratories, GE Healthcare, Biotronic SE & Co. KG, Bioscience Webster, Inc., Philips Healthcare, and Microport Scientific Corp . Are
Apply for TOC @ https://www.coherentmarketinsights.com/on going-insight/toc/1641Electrophysiology Devices Market Classification
The global electrophysiology devices market is divided on the basis of product type, application, end user and geography.
By product type
-Holter monitoring devices Electrocardiogram
Diagnostic electrophysiology catheters X-ray systems
3D mapping systems
Intracardiac Echocardiography Systems (ICE)
Implantable cardiac monitor
By Application
-Atrial Fibrillation
Ventricular Fibrillation
Wolff-Parkinson- White (WPW)
Tachycardia
Others
By End User
-Hospitals
Clinics
Others
By Geography
-North America
Europe
Asia
Pacific
Latin America
Middle East
Africa
About Integrated Market Insights:Coherent Market Insights is a leading market research and consulting firm that provides competitive analysis through action-packed syndicated research reports, custom market analysis, consulting services, and various recommendations on emerging market trends, technologies, and potential absolute dollar opportunities. Offers